Tyra Biosciences, Inc.
Prognozy (mln)
Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
Przychód (średnia) |
0.00 |
0.00 |
0.69 |
7.51 |
50.76 |
118.81 |
Przychód Δ r/r |
0.00% |
0.00% |
inf% |
992.19% |
576.07% |
134.07% |
Przychód (min) |
0.00 |
0.00 |
0.69 |
7.51 |
50.76 |
118.81 |
Przychód (max) |
0.00 |
0.00 |
0.69 |
7.51 |
50.76 |
118.81 |
EBITDA (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
EBIT (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
EBIT % |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Zysk netto (średni) |
-89.21 |
-121.14 |
-124.65 |
-147.91 |
-142.66 |
-120.35 |
Zysk netto % |
-inf% |
-inf% |
-18133.37% |
-1970.00% |
-281.06% |
-101.29% |
EPS (średnia) |
-1.55 |
-2.12 |
-2.38 |
-2.58 |
-2.49 |
-2.10 |
Liczba analityków (Przychody) |
0 |
0 |
4 |
4 |
2 |
3 |
Liczba analityków (EPS) |
6 |
6 |
6 |
5 |
2 |
1 |
symbol |
TYRA |
TYRA |
TYRA |
TYRA |
TYRA |
TYRA |